Cannabis stocks rally on policy reform hopes

Cannabis shares are stirring after years of drift, buoyed by hopes for federal rules on hemp products and hints that President Donald Trump could soften policy on marijuana. Verano posted $203 million in revenue and a $44 million loss, while Curaleaf and Trulieve report next week. Tilray’s stock has already jumped on strong results, and a Trump-shared video touting Medicare coverage for CBD sparked broad gains. Washington is weighing hemp regulations and possible marijuana rescheduling, even as some Republicans push curbs, leaving investors betting on clarity to unlock growth.

Reviewed by JQJO team

#cannabis #stocks #hemp #investors #marijuana